econdary Surgery in Patients With Serous Low Malignant Potential Ovarian Tumors With Peritoneal Implants

Conclusions: Secondary surgery seems to reduce the risk of recurrence in patients with serous LMPOT and peritoneal implants. Patients with residual disease are probably those likely to benefit from such surgery. Further studies are needed to confirm these preliminary results.